Chargement en cours...
Targeting putative mu opioid/metabotropic glutamate receptor-5 heteromers produces potent antinociception in a chronic murine bone cancer model
The therapeutic management of chronic pain associated with many cancers is problematic due to development of tolerance and other adverse effects during the disease progression. Recently we reported on a bivalent ligand (MMG22) containing both mu agonist and mGluR(5) antagonist pharmacophores that pr...
Enregistré dans:
| Publié dans: | Eur J Pharmacol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4259840/ https://ncbi.nlm.nih.gov/pubmed/25239072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2014.09.008 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|